Shenzhen Sangel Venture Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3

- Investments
-
72
- Portfolio
-
44
- Exits
-
12

Shenzhen Sangel Venture Capital General Information
Company Description
Founded in 2009, Shenzhen Sangel Venture Capital is a venture capital firm headquartered in Shenzhen, China. The firm seeks to invest in biomedical companies with a focus on life science, biotech, biopharma, medical devices, and digital health sectors.
Business Details
Website
www.sangelvc.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 2401/2402, Shenzhen Bay Venture Capital Building
- Nanshan District
- Shenzhen
- China
Shenzhen Sangel Venture Capital Investments (72)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
OxTium | 25-Jan-2024 | Early Stage VC | Decision/Risk Analysis | Generating Revenue | ||
Proviva Therapeutics | 22-Mar-2023 | Discovery Tools (Healthcare) | Clinical Trials - Phase 1 | |||
BioTroy Therapeutics | 07-Mar-2023 | Biotechnology | Pre-Clinical Trials | |||
Ascentawits Pharmaceutical | 16-Nov-2022 | Pharmaceuticals | Clinical Trials - Phase 2 | |||
Magpie Pharmaceuticals | 15-Aug-2022 | Drug Discovery | Clinical Trials - General | |||
Gigaceuticals | 15-Mar-2022 | Drug Discovery | Generating Revenue | |||
Tyercan | 24-Jan-2022 | Drug Discovery | Startup | |||
Sparx (Drug Discovery) | 31-Dec-2021 | Drug Discovery | Clinical Trials - Phase 1 | |||
Shenzhen GSH Bio-Tech | 01-Dec-2021 | Later Stage VC | Biotechnology | Generating Revenue | ||
China Immunotech | 10-Oct-2021 | Early Stage VC | Biotechnology | Pre-Clinical Trials |
Shenzhen Sangel Venture Capital Exits (12)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Ultivue | 09-Oct-2024 | Merger/Acquisition | |
Refuge Biotech | 03-Aug-2023 | ||
Thistory | 29-Mar-2023 | ||
InnerMedical | 31-Dec-2022 | ||
3D Medicines | 15-Dec-2022 | ||
Bontac Bio-Engineering | 25-Jun-2022 | ||
Predicine | 01-Apr-2022 | ||
Sirnaomics | 29-Dec-2021 | ||
Huaheng Biotech | 12-Apr-2021 | IPO | |
VersaPeutics | 01-Jul-2020 | Merger/Acquisition |
Shenzhen Sangel Venture Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Shenzhen Sangel Venture Capital Investments by Industry, Year, and Region
Shenzhen Sangel Venture Capital Co-Investors (38)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Co-Win Ventures | 2 |
![]() |
![]() |
||
Highlight Capital |
![]() |
![]() |
|||
Shenzhen Gaoxin Investment |
![]() |
![]() |
|||
Oriental Fortune Capital |
![]() |
![]() |
|||
Share Capital |
![]() |
![]() |
Shenzhen Sangel Venture Capital FAQs
-
What is Shenzhen Sangel Venture Capital?
Founded in 2009, Shenzhen Sangel Venture Capital is a venture capital firm headquartered in Shenzhen, China.
-
When was Shenzhen Sangel Venture Capital founded?
Shenzhen Sangel Venture Capital was founded in 2009.
-
Where is Shenzhen Sangel Venture Capital headquartered?
Shenzhen Sangel Venture Capital is headquartered in Shenzhen, China.
-
What is Shenzhen Sangel Venture Capital's total asset value?
Shenzhen Sangel Venture Capital has around
in total assets under management. -
How many investments has Shenzhen Sangel Venture Capital made?
Shenzhen Sangel Venture Capital has made 72 investments.
-
What has Shenzhen Sangel Venture Capital invested in?
Shenzhen Sangel Venture Capital has made numerous investments in companies like OxTium, Proviva Therapeutics, and BioTroy Therapeutics within the Decision/Risk Analysis, Discovery Tools (Healthcare), and Biotechnology industries.
-
What has Shenzhen Sangel Venture Capital invested in recently?
Shenzhen Sangel Venture Capital's latest investment was on 25-Jan-2024 in OxTium, a company within the Decision/Risk Analysis industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »